Top insider buys and sells disclosed Friday

The article is a roundup of disclosed insider and large-holder trading, led by $7.73 million of Hycroft Mining buying, $4.71 million of Forager Fund purchases in Repay Holdings, and $1.79 million of buying in Better Home & Finance. On the sell side, MACH Natural Resources saw a $71.2 million unit sale, Select Water Solutions had $36.7 million of insider selling, and Roku’s Charles Collier sold $21.6 million while also exercising options. The overall piece is informational rather than event-driven, but the size of the transactions may influence individual names.

Analysis

The common thread here is not “insider buying is bullish,” but that the highest-conviction activity is clustering where balance-sheet or valuation asymmetry is largest: distressed small/mid caps with operating leverage, versus mature winners where insiders are monetizing strength. That usually works best when the buyer is a control-like holder or sponsor with enough scale to shape outcomes; it is much less informative when the seller is simply de-risking into strength. In this tape, the market is rewarding momentum in some names while the smart money is fading it in others, which creates better relative-value than outright beta.

WTTR and MNR look like the clearest short-or-pair candidates because the insider actions line up with late-cycle behavior: sponsor distribution into good prints and elevated multiples. The more subtle point is that both names may have exhausted their “financial engineering” tailwind; if the next leg of upside requires operational beats rather than capital structure moves, the risk/reward deteriorates quickly over the next 1-3 months. Conversely, RPAY and BETRW are the kind of names where insider buying can matter more than the headline P&L because the float is smaller and a modest re-rate can be amplified if fundamentals merely stop worsening.

ROKU is the tricky one: the transaction reads as both a sale and an option-exercise event, so the signal is closer to tax/compensation monetization than outright bearishness. That makes it less attractive as a short, but also limits the upside interpretation; with the stock already re-rated, the better trade is to wait for a post-earnings volatility spike rather than chase the move. VOR sits in the middle: the insider selling is meaningful because it comes from a sophisticated holder, but the underlying setup still allows for a sharp squeeze if the market starts pricing asset value rather than just near-term clinical noise.

The contrarian miss is that the “cheap” names are not all equally cheap: some are cheap because liquidity is scarce and the next seller can overwhelm marginal demand, while others are cheap because the market is over-discounting transient execution issues. That distinction matters over the next several weeks, not years. The best expressions here are relative value and options-defined risk, not naked directional punts.

Key Decisions for Investors

• Short WTTR on strength or buy near-term puts; use a 2-6 week horizon. Risk/reward is attractive if multiple compression continues, with sponsor distribution signaling limited incremental upside unless fundamentals accelerate materially.
• Pair trade: long RPAY / short WTTR for 1-3 months. The long leg has insider accumulation into weakness and visible re-rating potential, while the short leg screens as a crowded, high-multiple winner with insider monetization risk.
• Avoid chasing ROKU outright; instead sell downside-supported put spreads into post-earnings volatility over the next 30-45 days. The exercise-sale combo suggests limited informational edge, so monetize implied vol rather than direction.
• Add VOR only via call spreads or a small tactical long for 4-8 weeks. Insider selling is a warning, but the stock can still overshoot higher if clinical sentiment improves; defined-risk structures are preferable to cash equity.
• If looking for catalyst-driven longs, accumulate BETRW on weakness with a 3-6 month horizon. Insider buying at this stage is more useful in a smaller float asset where any stabilization in sentiment can drive a sharp re-rate.